PharmaVoice ١٢ فبراير ٢٠٢٦ Lilly’s $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift
BioPharma Dive ٩ فبراير ٢٠٢٦ Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals
FierceBiotech ٩ فبراير ٢٠٢٦ Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
FierceBiotech ٤ فبراير ٢٠٢٦ Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout
BioPharma Dive ٤ فبراير ٢٠٢٦ Lilly soars again as fast-selling weight loss drugs top Wall Street projections
PharmaVoice ٢٩ يناير ٢٠٢٦ Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential
FierceBiotech ٢٩ يناير ٢٠٢٦ Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B